Overview
Satoru Sumitani practices practicing medicine in Kitamura, Japan.
His clinical expertise encompasses Atherosclerosis, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Satoru Sumitani
Is Satoru Sumitani a top-rated expert for Atherosclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Satoru Sumitani is classified as an Experienced expert for Atherosclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Satoru Sumitani participate in research or clinical trials?
Yes. Satoru Sumitani has published 10 articles and abstracts on conditions like Atherosclerosis. You can view a list of Satoru Sumitani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AtherosclerosisMr. Sumitani isExperienced. Learn about Atherosclerosis.
- Maturity Onset Diabetes of the YoungMr. Sumitani isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Type 2 Diabetes (T2D)Mr. Sumitani isExperienced. Learn about Type 2 Diabetes (T2D).